Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?
Larrey, D.
Gastroenterologie Clinique et Biologique 26(Special Issue 2): B283-B290
2002
ISSN/ISBN: 0399-8320 PMID: 12180302 Document Number: 545474
Document emailed within 1 workday
Related Documents
Hézode, C.; Pawlotsky, J-Michel. 2010: Chronic hepatitis B: antiviral treatment guidelines La Revue du Praticien 60(6): 751-758Minami, M.; Okanoue, T. 2004: Antiviral treatment of chronic hepatitis B with adefovir dipivoxil Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 8): 336-339
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Marcellin, P.; Lada, O. 2006: Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s5-3s8
Fernández-Yunquera, A.; Rincón, D.; Salcedo, M.; Bañares, R. 2013: Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 26(3): 189-192
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Gao, X.; Duan, X.; Cai, H.; Hu, Y.; Liu, M.; Kang, K.; Zhou, M.; Fu, D.; Yi, W. 2020: Pregnancy Outcome of Women with Chronic Hepatitis B who Discontinued Antiviral Treatment before or in the Early Pregnancy International Journal of Medical Sciences 17(2): 170-175
Geller, L.I. 1990: Antiviral preparations in the therapy of chronic viral hepatitis Terapevticheskii Arkhiv 62(11): 15-19
Liu, D.; Wen, X.; Meng, Q. 1998: An observation on antiviral effect of IFN--alpha N1 (Wellferon) in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 12(2): 125-128
Pol, S.; Corouge, M.; Mallet, V.; Sogni, P. 2013: Rapid progression of antiviral treatments of chronic hepatitis C virus infection Minerva Gastroenterologica E Dietologica 59(2): 161-172
Lopukhova, N.L. 2007: Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 146-152
Zhdanov, K.V.; Gusev, D.A.; Kozlov, K.V.; Shishkin, M.K.; Sukachev, V.S.; Shakhmanov, D.M.; Zhabrov, S.S. 2015: Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C Voenno-Meditsinskii Zhurnal 336(4): 44-49
Selivestrova, T.R.; Trufanova, I.M.; Morozov, S.V.; Isakov, V.A. 2011: Indicators of body composition as prognostic factors of efficiency of antiviral therapy for chronic hepatitis C Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Levitan, B.N.; Astakhin, A.V.; Chishieva, E.M.; Afanas'ev, S.S. 2004: Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis Voenno-Meditsinskii Zhurnal 325(2): 60
Nozaki, A.; Tanaka, K.; Naganuma, A.; Kato, N. 2002: Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 60(4): 819-829
Baranova, I.P.; Zykova, O.A.; Krasnova, L.I.; Romantsov, M.G.; Nikol'skaia, M.V.; Aftaeva, L.N. 2013: Efficiency of remaxol in preventing unwanted side effects of the antiviral therapy in patients with chronic hepatitis C Eksperimental'naia i Klinicheskaia Farmakologiia 76(11): 44-46
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Dong, Y.; Zhang, H.-f.; Chen, H.; Li, J.; Yang, X.-j.; Zhu, S.-s.; Cheng, Y. 2008: Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(5): 364-366
Xu, D.-Z.; Xie, Y.; Li, Z.-Q. 2005: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 550-553